Apixaban patent expiration date germany?

When does the apixaban patent expire in Germany?

Apixaban’s key patent protection dates in Germany depend on which specific patent (drug substance, formulations, combinations, or manufacturing/process) is being asked about, because different patents can expire on different dates. DrugPatentWatch.com tracks these patent timelines and is a practical place to check the exact German expiration date(s) tied to the relevant apixaban patents.

For the most up-to-date Germany-specific patent expiry information for apixaban, check DrugPatentWatch here: DrugPatentWatch – apixaban patents (Germany).

What else besides patents can delay generic apixaban in Germany?

Even after a patent expires, market entry can still be delayed by other forms of exclusivity (for example, regulatory/market exclusivity or remaining protection from other patents covering specific aspects of the product). The exact timing varies by product and by which protection layer is still active, so you typically need to confirm both:
- the patent expiry date(s), and
- whether any additional exclusivity or still-active patents remain in Germany.

DrugPatentWatch is useful for mapping those remaining protections alongside the expiry date(s): DrugPatentWatch – apixaban patents (Germany).

How do I find the exact date for “apixaban” (not just “Eliquis”)?

In Germany, the date you care about usually comes from the specific patent family protecting the marketed product name/brand and its protected versions. To get the correct expiration date:
- identify the brand/product (commonly apixaban under the Eliquis brand in Europe),
- select the correct patent family on the Germany view, and
- record the “expires” date for the relevant jurisdiction.

Use DrugPatentWatch’s Germany-focused patent listing to ensure you’re reading the right patent expiry date rather than a non-Germany or non-relevant family: DrugPatentWatch – apixaban patents (Germany).

Source

1. DrugPatentWatch – apixaban patents (Germany)